Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000062

Chief Executive Officer sold 1,729 shares at $69.69 ($120,494)

From the SEC's structured data for this filing

Trades in this filing

Klein Lawrence Otto · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Sale : show line 1 in the form −1,729 $69.69 $120,494 925,580 D
Open-market sales · 1,729 sh · avg $69.69 · $120,494
Loading xslF345X06/form4.xml…